Certain co-mutations, such as BCOR, BCORL1, NRAS, RUNX1, SRSF2 or STAG2, have been recently correlated with adverse impact in MDS-SF3B1 showing significantly different outcomes in comparison to mutation in SF3B1 alone [20]. Here, SF3B1 is linked to myelodysplastic syndrome.